James E. Dahlman
James E. Dahlman
Department of Biomedical Engineering, Georgia Institute of Technology
Verified email at bme.gatech.edu - Homepage
Title
Cited by
Cited by
Year
CRISPR-Cas9 knockin mice for genome editing and cancer modeling
RJ Platt, S Chen, Y Zhou, MJ Yim, L Swiech, HR Kempton, JE Dahlman, ...
Cell 159 (2), 440-455, 2014
10442014
Treating metastatic cancer with nanotechnology
A Schroeder, DA Heller, MM Winslow, JE Dahlman, GW Pratt, R Langer, ...
Nature Reviews Cancer 12 (1), 39-50, 2012
9082012
Emerging frontiers in drug delivery
MW Tibbitt, JE Dahlman, R Langer
Journal of the American Chemical Society 138 (3), 704-717, 2016
4892016
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
JE Dahlman, C Barnes, OF Khan, A Thiriot, S Jhunjunwala, TE Shaw, ...
Nature nanotechnology 9 (8), 648, 2014
4282014
Small RNA combination therapy for lung cancer
W Xue, JE Dahlman, T Tammela, OF Khan, S Sood, A Dave, W Cai, ...
Proceedings of the National Academy of Sciences 111 (34), E3553-E3561, 2014
1892014
Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure
HB Sager, M Hulsmans, KJ Lavine, MB Moreira, T Heidt, G Courties, ...
Circulation research 119 (7), 853-864, 2016
1722016
Silencing or stimulation? siRNA delivery and the immune system
KA Whitehead, JE Dahlman, RS Langer, DG Anderson
Annual review of chemical and biomolecular engineering 2, 77-96, 2011
1722011
Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease
JE Dahlman, OO Abudayyeh, J Joung, JS Gootenberg, F Zhang, ...
Nature biotechnology 33 (11), 1159-1161, 2015
1462015
RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction
HB Sager, P Dutta, JE Dahlman, M Hulsmans, G Courties, Y Sun, T Heidt, ...
Science translational medicine 8 (342), 342ra80-342ra80, 2016
942016
Genetic and hypoxic alterations of the micro RNA‐210‐ISCU 1/2 axis promote iron–sulfur deficiency and pulmonary hypertension
K White, Y Lu, S Annis, AE Hale, BN Chau, JE Dahlman, C Hemann, ...
EMBO molecular medicine 7 (6), 695-713, 2015
842015
Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature
OF Khan, EW Zaia, S Jhunjhunwala, W Xue, W Cai, DS Yun, CM Barnes, ...
Nano letters 15 (5), 3008-3016, 2015
712015
Challenges in carrier‐mediated intracellular delivery: moving beyond endosomal barriers
MP Stewart, A Lorenz, J Dahlman, G Sahay
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8 (3 …, 2016
622016
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
JE Dahlman, KJ Kauffman, Y Xing, TE Shaw, FF Mir, CC Dlott, R Langer, ...
Proceedings of the National Academy of Sciences 114 (8), 2060-2065, 2017
582017
Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling
S Yun, M Budatha, JE Dahlman, BG Coon, RT Cameron, R Langer, ...
Nature cell biology 18 (10), 1043-1053, 2016
502016
Conjugated lipomers and uses thereof
JE Dahlman, AD Schroeder, DG Anderson, RS Langer, CG Levins
US Patent 9,238,716, 2016
462016
Ionizable Amphiphilic Dendrimer‐Based Nanomaterials with Alkyl‐Chain‐Substituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo
OF Khan, EW Zaia, H Yin, RL Bogorad, JM Pelet, MJ Webber, I Zhuang, ...
Angewandte Chemie International Edition 53 (52), 14397-14401, 2014
442014
A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation
K Paunovska, CD Sago, CM Monaco, WH Hudson, MG Castro, ...
Nano letters 18 (3), 2148-2157, 2018
422018
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
J Dahlman, RJ PLATT, DG Anderson, R Langer, F Zhang
402015
Alkane-modified short polyethyleneimine for siRNA delivery
A Schroeder, JE Dahlman, G Sahay, KT Love, S Jiang, AA Eltoukhy, ...
Journal of controlled release 160 (2), 172-176, 2012
392012
Macrophage notch ligand delta-like 4 promotes vein graft lesion development: implications for the treatment of vein graft failure
J Koga, T Nakano, JE Dahlman, JL Figueiredo, H Zhang, J Decano, ...
Arteriosclerosis, thrombosis, and vascular biology 35 (11), 2343-2353, 2015
382015
The system can't perform the operation now. Try again later.
Articles 1–20